4DMedical Limited (ASX:4DX)
1.310
+0.155 (13.42%)
Sep 4, 2025, 4:18 PM AEST
4DMedical Revenue
In the fiscal year ending June 30, 2025, 4DMedical had annual revenue of 5.85M AUD with 55.91% growth. 4DMedical had revenue of 2.96M in the half year ending June 30, 2025, with 1,171.16% growth.
Revenue
5.85M
Revenue Growth
+55.91%
P/S Ratio
104.93
Revenue / Employee
40.37K
Employees
145
Market Cap
614.22M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 5.85M | 2.10M | 55.91% |
Jun 30, 2024 | 3.75M | 3.04M | 422.45% |
Jun 30, 2023 | 718.58K | -335.72K | -31.84% |
Jun 30, 2022 | 1.05M | 837.32K | 385.90% |
Jun 30, 2021 | 216.98K | -1.02M | -82.40% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.79B |
Ansell | 3.06B |
Telix Pharmaceuticals | 1.01B |
Mesoblast | 26.23M |